Skip to main content
Research project

Dr S Wilson: 'A randomised multi-centre, double-blind, placebo-controlled, parallel-group trial to explore the effects of omalizumab on airway inflammation and severe IgE-medicated asthma'

Lead researcher:
Research funder:
Novartis Pharma AG
Not active


Lead researcher

Doctor Susan Wilson

Associate Professor

Research interests

  • The effects of pollutants on bronchial inflammation in asthma, rhinitis and COPD
  • Relationship between squamous metaplasia, smoking history and COPD

Connect with Susan

Back to top